We are live on ! Find out more
PP

PDT Partners Portfolio holdings

AUM $1.69B
1-Year Est. Return 74.01%
This Fund
S&P 500
This Quarter Est. Return
+11.33%
1 Year Est. Return
+74.01%
3 Year Est. Return
+179.69%
5 Year Est. Return
+210.81%
10 Year Est. Return
+1,321.68%
AUM
$3.69B
AUM Growth
-$387M
Cap. Flow
-$666M
Cap. Flow %
-18.06%
Top 10 Hldgs %
9%
Holding
1,949
New
491
Increased
413
Reduced
534
Closed
485

Top Buys

Rank Stock Value
1
CTRA
Coterra Energy
CTRA
+$37.1M
2
MU icon
Micron Technology
MU
+$36.1M
3
CVS icon
CVS Health
CVS
+$32.7M
4
GE icon
GE Aerospace
GE
+$32.1M
5
SNDK
SANDISK CORP
SNDK
+$24.8M

Top Sells

Rank Stock Value
1
TSLA icon
Tesla
TSLA
+$55.9M
2
AGN
Allergan Inc
AGN
+$45M
3
YHOO
Yahoo Inc
YHOO
+$43.5M
4
LLY icon
Eli Lilly
LLY
+$38.1M
5
LEA icon
Lear
LEA
+$29.1M

Sector Composition

Rank Sector Weight
1 Technology 13.75%
2 Consumer Discretionary 12.18%
3 Industrials 11.89%
4 Healthcare 11.02%
5 Financials 9.77%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DLX icon
801
Deluxe
DLX
$1.22B
$913K 0.02%
21,912
-53,843
-71% -$2.16M
MATV icon
802
Mativ Holdings
MATV
$455M
$912K 0.02%
+15,063
New +$850K
ARIA
803
DELISTED
Ariad Pharmaceuticals Inc
ARIA
$911K 0.02%
+49,500
New +$961K
RGS icon
804
Regis Corp
RGS
$68.3M
$906K 0.02%
3,086
+2,361
+326% +$782K
CAVM
805
DELISTED
Cavium, Inc.
CAVM
$903K 0.02%
21,925
-48,900
-69% -$1.84M
FDML
806
DELISTED
Federal-Mogul Holdings Corporation
FDML
$903K 0.02%
+53,791
New +$805K
PKX icon
807
POSCO
PKX
$16.1B
$900K 0.02%
+12,222
New +$889K
BAP icon
808
Credicorp
BAP
$31.1B
$899K 0.02%
7,273
-54,948
-88% -$6.55M
MORN icon
809
Morningstar
MORN
$6.94B
$898K 0.02%
11,326
-3,513
-24% -$272K
RPXC
810
DELISTED
RPX Corporation
RPXC
$897K 0.02%
51,192
-56,462
-52% -$964K
FLY
811
DELISTED
Fly Leasing Limited
FLY
$897K 0.02%
64,599
+46,572
+258% +$655K
CFN
812
DELISTED
CAREFUSION CORPORATION
CFN
$895K 0.02%
+24,244
New +$905K
AES icon
813
AES
AES
$10.6B
$888K 0.02%
66,819
+41,679
+166% +$535K
VEON icon
814
VEON
VEON
$3.58B
$884K 0.02%
+3,008
New +$801K
AOS icon
815
A.O. Smith
AOS
$8.61B
$883K 0.02%
39,060
-142,666
-79% -$2.98M
CI icon
816
Cigna
CI
$77B
$877K 0.02%
+11,405
New +$891K
PFPT
817
DELISTED
Proofpoint, Inc.
PFPT
$877K 0.02%
27,296
+5,601
+26% +$158K
STRZA
818
DELISTED
Starz - Series A
STRZA
$877K 0.02%
31,190
-11,834
-28% -$292K
BRSL
819
Brightstar Lottery PLC
BRSL
$1.93B
$869K 0.02%
45,900
-79,700
-63% -$1.52M
OLN icon
820
Olin
OLN
$2.49B
$865K 0.02%
37,500
+26,370
+237% +$624K
CRL icon
821
Charles River Laboratories
CRL
$10.8B
$862K 0.02%
18,635
-26,573
-59% -$1.22M
CRAY
822
DELISTED
Cray, Inc.
CRAY
$861K 0.02%
35,783
-4,682
-12% -$114K
MYE icon
823
Myers Industries
MYE
$1.23B
$859K 0.02%
+42,696
New +$796K
ZBH icon
824
Zimmer Biomet
ZBH
$17.8B
$857K 0.02%
10,750
-2,904
-21% -$229K
HURN icon
825
Huron Consulting
HURN
$1.89B
$856K 0.02%
16,272
+9,413
+137% +$464K

Similar funds

PDT Partners's Q3 2013 Portfolio in Review

As of Q3 2013, PDT Partners held 1,949 positions worth $3.69B, down 9.5% from $4.08B the previous quarter. Its ten largest holdings account for 9% of the portfolio.

PDT Partners withdrew a net $666M in Q3 2013, closing 485 positions and reducing 534 holdings. Its most notable exit was SLB Ltd, an estimated $21.7M position sold in full.

By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 11% a quarter earlier, followed by Consumer Discretionary and Industrials.

Against the trend, PDT Partners opened a new position in Micron Technology worth $43.4M.

  • PDT Partners's largest Q3 2013 buy was Micron Technology: 2,486,199 shares worth $43.4M.
  • PDT Partners added most to Coterra Energy in Q3 2013, an estimated $37.1M increase.
  • PDT Partners's biggest Q3 2013 reduction was Tesla, cutting an estimated $55.9M.
  • PDT Partners fully exited SLB Ltd in Q3 2013, selling an estimated $21.7M.
  • PDT Partners's ten largest holdings make up 9% of its $3.69B portfolio in Q3 2013.
  • PDT Partners opened 491 new positions and closed 485 in Q3 2013.
  • PDT Partners's portfolio value fell 9.5% quarter-over-quarter to $3.69B.

Based on PDT Partners's 13F filing for Q3 2013, filed 14 Nov 2013.